Dr. Brandon Anthony Zielinski

M.D., PH.D. | Neurology


  100 Mario Capecchi Dr, Salt Lake City
     Utah, 84113-1103
  801-587-7575    Maps & Directions
Dr. Brandon Anthony Zielinski is a Salt Lake City, Utah based neurologist who is specialized in Neurology. His current practice location is 100 Mario Capecchi Dr, Salt Lake City. Patients can reach him at 801-587-7575. Dr. Brandon Anthony Zielinski is M.D., PH.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1154539112.
Dr. Brandon Anthony Zielinski specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Brandon Anthony Zielinski speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Brandon Anthony Zielinski
Specialization: Neurology
Gender:Male
Credentials: M.D., PH.D.
Practice Address:100 Mario Capecchi Dr, Salt Lake City,
Utah, 84113-1103
Phone:801-587-7575
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1154539112
NPI Enumeration Date: 21 May, 2007
NPI Last Update On: 20 Dec, 2021

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Brandon Anthony Zielinski
Po Box 413021,
Salt Lake City, Utah
Zip: 84141-3021
Phone Number: 801-213-3900
Patients can reach Dr. Brandon Anthony Zielinski at 100 Mario Capecchi Dr, Salt Lake City, Utah or can call to book an appointment on 801-587-7575.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.